Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma

Published:2016-08-11 Issue:6 Volume:47 Page:533-541
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Tsunematsu Seiji¹,Suda Goki¹,Yamasaki Kazushi¹,Kimura Megumi¹,Takaaki Izumi¹,Umemura Machiko¹,Ito Jun¹,Sato Fumiyuki¹,Nakai Masato¹,Sho Takuya¹,Morikawa Kenichi¹,Ogawa Koji¹,Kamiyama Toshiya²,Taketomi Akinobu²,Sakamoto Naoya¹

Affiliation:

1. Departments of Gastroenterology and Hepatology, Graduate School of Medicine; Hokkaido University; Sapporo Japan

2. Gastroenterological Surgery 1, Graduate School of Medicine; Hokkaido University; Sapporo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12775/fullpdf

Reference20 articles.

1. Hepatocellular carcinoma;Llovet;Lancet,2003

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008